ADMA Biologics Inc.

ADMA | NASDAQ

Price Alert Chart Builder DCF Calculator

$9.51

+$0.40 (+4.39%)

At close: Sep 21, 2026, 4:00 PM ET

$9.48

-$0.03 (-0.32%)

Pre-market: Sep 22, 2026, 8:16 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	146.93M	197.67M	-28.24M	-65.9M	-71.65M	-75.75M
Depreciation & Amortization	8.1M	8.05M	8.33M	7.11M	5.5M	3.94M
Stock-Based Compensation	20.03M	13.62M	6.19M	5.22M	3.49M	2.86M
Other Working Capital	2.74M	-2.78M	7.58M	6.4M	5.49M	2.56M
Other Non-Cash Items	3.92M	2.16M	32.64M	12.35M	1.75M	1.64M
Deferred Income Tax	11.02M	-84.28M	n/a	n/a	220.76K	-910.1K
Change in Working Capital	-139.6M	-18.54M	-10.12M	-18.29M	-51.68M	-33.78M
Operating Cash Flow	50.4M	118.67M	8.8M	-59.51M	-112.37M	-102M
Capital Expenditures	-22.58M	-8.58M	-4.98M	-13.91M	-13.51M	-12.73M
Cash Acquisitions	1M	n/a	n/a	n/a	n/a	2K
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-316K	-349K	-210K	n/a	n/a	2K
Investing Cash Flow	-21.89M	-8.58M	-4.98M	-13.91M	-13.51M	-12.72M
Debt Repayment	-3.18M	-60M	-23.6M	51.71M	-34K	13.52M
Common Stock Repurchased	-31.94M	n/a	-1.42M	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-11.89M	-5.8M	-13.97M	-7.51M	-62K	-816.57K
Financial Cash Flow	-44.02M	-58.3M	-38.99M	108.85M	121.05M	143.9M
Net Cash Flow	-15.52M	51.8M	-35.17M	35.43M	-4.83M	29.17M
Free Cash Flow	27.82M	110.1M	3.82M	-73.42M	-125.88M	-114.73M
Adj. Free Cash Flow	7.8M	96.48M	-2.37M	-78.63M	-129.37M	-117.58M
Maintenance CapEx	-31.15K	n/a	n/a	n/a	n/a	n/a
Growth CapEx	-22.54M	-8.58M	-4.98M	-13.91M	-13.51M	-12.73M
Owner Earnings	50.36M	118.67M	8.8M	-59.51M	-112.37M	-102M